Miller Henry I
Hoover Institution, Stanford University, Stanford, California 94305-6010, USA.
Nat Rev Drug Discov. 2002 Dec;1(12):1007-8. doi: 10.1038/nrd965.
Biotechnology applied to pharmaceuticals has made significant contributions to medicine during the past 20 years. Although important products will continue to emerge, benefiting patients and perhaps lowering medical costs, there are too many biopharmaceutical companies chasing too few products, which are themselves over-regulated and incredibly expensive to test and bring to market.
在过去20年里，应用于制药领域的生物技术为医学做出了重大贡献。尽管重要产品将不断涌现，使患者受益并可能降低医疗成本，但生物制药公司数量过多，而产品却太少，这些产品本身受到过度监管，测试和推向市场的成本高得惊人。
